IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

IRLAB Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	392	558	389	1,987	2,277	2,173
Market Cap Growth	-49.10%	43.33%	-80.42%	-12.75%	4.76%	37.75%
Enterprise Value	370	527	271	1,699	1,853	2,006
Last Close Price	7.56	10.75	7.50	38.30	44.00	42.00
PE Ratio	-	-	-	-	43.97	-
PS Ratio	3.82	5.89	68.51	32.49	10.96	7244.78
PB Ratio	84.66	17.09	3.36	6.83	5.70	6.25
P/TBV Ratio	-	-	5.65	8.14	6.38	8.16
P/FCF Ratio	-	-	-	-	17.80	-
P/OCF Ratio	-	-	-	-	17.70	-
EV/Sales Ratio	3.60	5.57	47.82	27.79	8.92	6687.21
EV/EBITDA Ratio	-	-	-	-	34.92	-
EV/EBIT Ratio	-	-	-	-	35.25	-
EV/FCF Ratio	-17.41	-	-	-	14.49	-
Debt / Equity Ratio	14.35	1.85	0.24	0.01	0.02	0.01
Debt / EBITDA Ratio	-	-	-	-	0.12	-
Debt / FCF Ratio	-	-	-	-	0.05	-
Asset Turnover	0.69	0.60	0.02	0.15	0.49	0.00
Quick Ratio	0.68	0.80	3.28	8.19	5.95	13.47
Current Ratio	0.68	0.80	3.37	8.31	6.07	13.56
Return on Equity (ROE)	-191.89%	-112.03%	-87.48%	-32.86%	13.86%	-34.61%
Return on Assets (ROA)	-27.88%	-29.96%	-44.96%	-17.59%	7.80%	-19.80%
Return on Capital (ROIC)	-47.11%	-39.72%	-51.38%	-19.98%	8.68%	-21.31%
Return on Capital Employed (ROCE)	-	-	-	-	13.00%	-
Earnings Yield	-19.91%	-14.91%	-45.72%	-5.71%	2.27%	-4.22%
FCF Yield	-5.42%	-11.80%	-42.45%	-7.32%	5.62%	-4.12%
Buyback Yield / Dilution	-	-	-0.07%	-0.16%	-8.54%	-17.45%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.